Stocks making the biggest moves midday: Abercrombie & Fitch, Palo Alto Networks, Moderna and more
These are the stocks posting the largest moves in midday trading....…
41,120$
7,50%
Echtzeit-Aktienkurs Moderna Inc.
Bid:
Ask:
Nachrichten zur Moderna Inc. Aktie
Opening Bell: Moderna, Pfizer, Palo Alto, Broadcom, Nvidia, Uber, Intuitive Surgical
Die Sorgen um den US-Schuldenstreit belasten die amerikanischen Aktienmärkte weiterhin. Für den Dow Jones ging es gestern um 0,7 Prozent…
Opening Bell: Dow Jones verliert 100 Punkte; Fed-Protokoll, Palo Alto Networks, Nvidia, Uber, Intuitive Surgical, Moderna im Fokus
Im Streit um die Anhebung der Schuldengrenze in den USA verrinnt die Zeit und je lauter die Uhr tickt, desto…
Billionaire Professor Tim Springer Donates $210 Million To Biomedical Research Nonprofit
Springer, a Harvard immunology professor, made a fortune as a founding investor in Covid-19 vaccine maker Moderna. He hopes his…
Stocks making the biggest moves premarket: Moderna, Kohls, Intuit, Analog Devices & more
These are the stocks posting the largest moves in premarket trading....…
BioNTech, CureVac und Moderna im Aufwind: Das sorgt für frische Fantasie
Die Aktien der drei bekannten mRNA-Spezialisten BioNTech, Moderna und CureVac konnten am Dienstag jeweils zwischen acht und zehn Prozent an…
Märkte am Morgen: Gold, Moderna, BioNTech, DAX, Vonovia, Porsche AG, Mercedes-Benz, LVMH, Kering
Eine Einigung im US-Schuldenstreit lässt weiter auf sich warten. Das belastet weiterhin die Aktienmärkte dies- und jenseits des Atlantiks. Für…
Märkte am Morgen: DAX startet schwächer; Moderna, Biontech, Porsche AG, Vonovia, Mercedes Benz, LVMH, Kering im Fokus
Die Hängepartie im US-Schuldenstreit nervt die Anleger. Der DAX dürfte der Wall Street am Mittwoch folgen und schwächer starten. Der…
Why did Moderna stock jump today? Renewed COVID fears
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Schlussglocke USA: Wall Street unter Druck - Broadcom, Chevron und Moderna steigen gegen den Trend
Moderate Abgaben bei den Standardwerten an der Wall Street und größere Verluste an der technologielastigen Nasdaq-Börse: So präsentierten sich die…
Is Trending Stock Moderna, Inc. (MRNA) a Buy Now?
Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
Is Moderna Stock a Buy Now?
The companys post-pandemic plans are slowly taking shape....…
Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy
Interim data from a study shows that Modernas (MRNA) investigational therapy for propionic acidemia (PA) exhibited early signs of dose-dependent…
Moderna shares Phase 1/2 data for mRNA therapy targeted at rare metabolic disorder
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
A 114-Year-Old Fund That Chases Cutting-Edge Investments
The world’s largest closed-end fund, Scottish Mortgage Investment Trust, is now trading at a 23% discount to its net asset…
Could Latecomer Moderna Match Big Pharma Rivals in RSV?
RSV is a key part of Modernas respiratory vaccine business....…
Biden to nominate cancer surgeon Monica Bertagnolli to lead National Institutes of Health
NIH which funds medical research played a key role in developing the messenger RNA technology that underlies the Covid vaccine…
Is It Too Late to Buy Moderna Stock?
Moderna shares fell last year and are on the decline again....…
Judge Orders FDA To Speed Up Release Of COVID-19 Vaccine Trial Data From 23.5 Years To Just 2
Judge Orders FDA To Speed Up Release Of COVID-19 Vaccine Trial Data From 23.5 Years To Just 2
…
Covid-19 vaccines cause myocarditis in youngsters, says study
By Luís Batistela The vaccines from Pfizer and Moderna are causing myocarditis in young people between 13 and 21 years…
Heres why Covid vaccines will still be free for uninsured Americans as public health emergency ends
The Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots…
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
Company entered into strategic collaboration with Moderna to use Generation Bios proprietary non-viral genetic medicine delivery system for two liver…
Vaccine maker chops a quarter of global workforce as COVID eases
Novavax seeks to slash expenses while dealing with an uncertain future after losing the vaccination race against rivals Pfizer and…
Is Moderna a Value Stock to Buy Right Now?
The company has several potentially huge winners in its pipeline....…
Youngest Companies in the Fortune 500
Pfizer and Moderna – thanks to the coronavirus pandemic, these two pharmaceutical companies have become household names. Both companies, known…
Is Moderna Building a Respiratory Vaccine Empire?
Moderna investors may win big if they hold on for the long term....…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.428.125$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-05-04...…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.251.498$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-05-03...…
Form 8-K Moderna, Inc. For: May 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna (MRNA) Q1 2023 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2023....…
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Moderna (MRNA) beats expectations for both earnings and sales. The company posts higher-than-expected product sales from its COVID vaccine...…
Moderna in fill-finish agreement with Novocol Pharma for mRNA vaccines
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna tops 1Q forecasts; vaccine sales plunge as expected
Sales of Modernas COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall Street expected this and…
Moderna-Aktie steigt an der NASDAQ: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen
Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…
Moderna-Aktie an der NASDAQ in Grün: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen
Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…
Covid-Impfstoffhersteller Moderna bekommt sinkende Nachfrage zu spüren
CAMBRIDGE (dpa-AFX) - Das Biotechunternehmen Moderna bekommt die sinkende Nachfrage nach seinem Covid-19-Impfstoff zu spüren.…
Moderna-Aktie vorbörslich an der NASDAQ in Grün: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen
Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…
Moderna-Aktie vorbörslich an der NASDAQ in Rot: Moderna mit rückläufigem Gewinn und Umsatz - Erwartungen dennoch übertroffen
Der Impfstoffhersteller Moderna hat seine Bilanz offen gelegt....…
ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
First quarter 2023 revenues of $1.9 billion; GAAP net income of $79 million and GAAP diluted EPS of $0.19Company in…
UPDATE 1-Moderna beats COVID vaccine sales expectations as deferred revenue rolls in
...(Adds shares)
By Patrick Wingrove and Leroy Leo
May 4 (Reuters... Reuters.
Moderna continues to expect the U.S. annual COVID-19 market......…
Moderna stock up premarket after posting surprise profit and revenue that crushed estimates
Moderna Inc.’s stock MRNA rose 1.8% premarket Thursday, after the biotech blew past estimates for first-quarter earnings, even as profit…
Moderna beats COVID vaccine sales expectations as deferred revenue rolls in
...By Patrick Wingrove and Leroy Leo
(Reuters) - Moderna Inc...," Moderna Chief Commercial Officer Arpa…
Form 8-K Moderna, Inc. For: May 04
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna GAAP EPS of $0.19 beats by $1.94, revenue of $1.9B beats by $730M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna, Inc.: Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia to be Presented at the 2023 ASGCT Annual Meeting
After completing enrollment in 5 dose cohorts, and with no dose-limiting safety signals observed to date by the independent DSMB,…
Moderna Reports Earnings. What Comes After Covid Vaccine Will Be the Focus.
As the biotech reports first-quarter earnings, the focus will be on Moderna's pipeline of future vaccines and cancer treatments and…
FDA approves GSKs RSV vaccine for older adults, worlds first shot against virus
The FDAs approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that…
All eyes on Moderna Q1 earnings with focus on pipeline beyond COVID
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Should You Buy Moderna (MRNA) Ahead of Earnings?
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…
Moderna plans to open an enterprise solutions hub in the Philippines
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…